| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.04. | Italy leads the way on child genetic disease diagnosis | ||
| 20.04. | Update: Lilly makes $7bn bid for in vivo CAR-T firm Kelonia | ||
| 20.04. | UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator | ||
| 20.04. | Lilly said to be readying $2bn-plus bid for Kelonia | ||
| 20.04. | AZ is three for three with COPD hope tozorakimab | ||
| 20.04. | UCB cuts $1.15bn deal to buy epilepsy biotech Neurona | ||
| 17.04. | Obesity biotech Kailera's record-breaking IPO | ||
| 17.04. | OpenAI introduces GPT-Rosalind, its drug discovery AI | ||
| 17.04. | Multiple myeloma drug Blenrep backed for wider NHS use | ||
| 17.04. | Trump names Erica Schwartz to fill leadership void at CDC | ||
| 16.04. | UK says it has hit target on commercial trial set-up times | ||
| 16.04. | Lift for UK healthtech as fund bags £100m from national bank | ||
| 16.04. | FDA accelerated approval path needs improvement, says ICER | ||
| 16.04. | Lilly says Foundayo safety confirmed in ACHIEVE-4 trial | ||
| 16.04. | Beeline raises $300m for BMS drugs, and other biofinancings | ||
| 16.04. | Most patients "won't see benefit" with Alzheimer's drugs | ||
| 15.04. | Novartis CEO joins board of "responsible" AI firm Anthropic | ||
| 15.04. | Scientists issue call to arms over antifungal resistance | ||
| 15.04. | Daiichi exits OTC, with $1.55bn unit sale to Suntory | ||
| 15.04. | Parkinson's charity partners Biognosys on biomarker project | ||
| 15.04. | Amazon launches its AI drug discovery platform | ||
| 15.04. | FDA seeks safety data for Lilly's oral GLP-1 Foundayo | ||
| 14.04. | FDA renews criticism of trial sponsors over transparency | ||
| 14.04. | Novo Nordisk partners OpenAI on R&D "transformation" | ||
| 14.04. | Travere claims first FDA OK in rare kidney disease FSGS |